Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO92922949Aexternal-prioritypatent/NO922949L/en
Publication of NO931338LpublicationCriticalpatent/NO931338L/en
Application filed by Medivir AbfiledCriticalMedivir Ab
Priority to NO931338ApriorityCriticalpatent/NO931338D0/en
Publication of NO931338D0publicationCriticalpatent/NO931338D0/en
Forbindelse med formel (IA) farmasøytisk formulering som omfatter forbindelsen og anvendelse av forbindelsen for fremstilling av et medikament nyttig for inhibering av replikasjon av HIV, behandling og inhlbisjon av HIV i et menneske og behandling og inhibisjon av ervervet immunsvikt syndrom l et menneske, er beskrevet.Compound of formula (IA) pharmaceutical formulation comprising the compound and use of the compound for the preparation of a drug useful for inhibiting HIV replication, treatment and inhibition of HIV in a human, and treatment and inhibition of acquired immunodeficiency syndrome in a human are described. .
NO931338A1991-08-021993-04-07
RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES
NO931338D0
(en)
INHIBITING PYRIMIDINES OF HIV REPLICATION, A PROCESS FOR PREPARATION, THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITIONS, AND A PROCESS TO PREPARE THEM
DERIVED FROM THE 3-ARIL-2-HYDROXIPROPIONIC ACID, PROCESS AND INTERMEDIARY FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS, USE OF SUCH COMPOUND IN THE PREPARATION OF A MEDICINAL PRODUCT, METHOD FOR THE PROPHYLAXIS AND / OR TREATMENT OF CLINIC ASSOCIATED RESISTANCES AND FORMULATION
The use of saredutan and its pharmaceutically acceptable salts for the preparation of medicinal products useful in the treatment or prevention of all mental disorders, adaptation disorders and various anxiety-depression disorders.
The use of the active substance flupirtine or its pharmacologically acceptable salts as a drug for the prevention and treatment of diseases associated with damage to the cell system